Dr. Chantelle Thomas speaks with Dr. Daniel Zimmerman and Heather Hamilton of Acheron Psychiatry in lower Manhattan about the evolution of ketamine-assisted psychotherapy (KAP) in their practice and in the broader field. They trace their entry into psychedelic medicine, discuss the shift from symptom-focused treatment toward insight-oriented psychotherapy, and explore dosing philosophy, music, risk, and the influence of practicing in New York City. The conversation balances enthusiasm with caution, emphasizing pacing, integration, and ethical humility in a rapidly expanding field.

(09:29) Ketamine as Catalyst — Moving beyond symptom management toward medicine-assisted psychotherapy.

(26:58) Dosing and Risk — IM vs lozenge, high-dose concerns, and integration pacing.

(40:07) Music and Setting — Curated playlists and environment as therapeutic container.

(46:55) The New York Context — Speed, ambition, trauma history, and slowing down.

(53:59) Group KAP — Community healing and expanding into intentional group work.

Dr. Chantelle Thomas, Executive Clinical Director Windrose Recovery: https://windroserecovery.com/

Heather Hamilton, Psychotherapist, LMHC Acheron Psychiatry: https://acheronpsych.com/heather-hamilton/

Daniel Zimmerman, M.D., Psychiatrist , Founder Acheron Psychiatry: https://acheronpsych.com/daniel-zimmerman/